KKR & Co.-backed venture capital firm Catalio Capital Management gathered more than $400 million for its latest fund, a ...

Could synthetic macrocyclic peptides be the Next Big Thing to lift biotech? A potential $1.5 billion deal suggests things are ...

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax efficient and ...

The NATO Innovation Fund has made its first investment in a biotechnology company, it said on Monday, seeking to enhance ...

Triangle gains public company with merger Breakthrough! RTP biotech sees progress in restoring vision to blind Breakthrough!

The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Bioo CEO Pablo Vidarte says his bioluminescent landscaping will arrive in Dubai within months, following successful ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

The self-funded medical beauty market has gradually integrated into consumers' daily life, combining the pursuit of outer ...